Overexpression of the adeB Efflux Pump Gene in Tigecycline-Resistant Acinetobacter baumannii Clinical Isolates and Its Inhibition by (+)Usnic Acid as an Adjuvant
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of the adeB Efflux Pump Gene in Tigecycline-Resistant Acinetobacter baumannii Clinical Isolates and Its Inhibition by (+)Usnic Acid as an Adjuvant
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 9, Pages 1037
Publisher
MDPI AG
Online
2021-08-26
DOI
10.3390/antibiotics10091037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acinetobacter baumannii Antibiotic Resistance Mechanisms
- (2021) Ioannis Kyriakidis et al. Pathogens
- Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal
- (2020) Santosh Kumar Yadav et al. Infection and Drug Resistance
- Synergistic Effect between Usnic Acid and Polymyxin B against Resistant Clinical Isolates of Pseudomonas aeruginosa
- (2020) Sérgio Dias da Costa Júnior et al. Evidence-based Complementary and Alternative Medicine
- The role of RND-type efflux pumps in multidrug-resistant mutants of Klebsiella pneumoniae
- (2020) Rui Ting Ni et al. Scientific Reports
- Determination of Drug Efflux Pump Efficiency in Drug-Resistant Bacteria Using MALDI-TOF MS
- (2020) Wen-Jung Lu et al. Antibiotics-Basel
- Usnic Acid Potassium Salt: Evaluation of the Acute Toxicity and Antinociceptive Effect in Murine Model
- (2019) Araújo et al. MOLECULES
- Usnic acid modifies modifies MRSA drug resistance through down‐regulation of proteins involved in peptidoglycan and fatty acid biosynthesis
- (2019) Sneha Sinha et al. FEBS Open Bio
- Overexpression of AdeABC efflux pump associated with tigecycline resistance in clinical Acinetobacter nosocomialis isolates
- (2018) Ya-Sung Yang et al. CLINICAL MICROBIOLOGY AND INFECTION
- Usnic acid and its derivatives for pharmaceutical use: a patent review (2000–2017)
- (2018) Olga A. Luzina et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Antimicrobial and Efflux Inhibitor Activity of Usnic Acid Against Mycobacterium abscessus
- (2018) Ivy Ramis et al. PLANTA MEDICA
- Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
- (2018) Muhammad Asif et al. Infection and Drug Resistance
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Infections Due to Acinetobacter baumannii in the ICU: Treatment Options
- (2017) George Zhanel et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients
- (2016) Constantinos Tsioutis et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin-resistant Acinetobacter baumannii ventilator-associated pneumonia in a tertiary care hospital: an evolving threat
- (2016) M. Gupta et al. JOURNAL OF HOSPITAL INFECTION
- Over expression of AdeABC and AcrAB-TolC efflux systems confers tigecycline resistance in clinical isolates of Acinetobacter baumannii and Klebsiella pneumoniae
- (2016) Yin Yuhan et al. Revista da Sociedade Brasileira de Medicina Tropical
- Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens
- (2015) J.M. Pogue et al. CLINICAL MICROBIOLOGY AND INFECTION
- The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
- (2015) Xian-Zhi Li et al. CLINICAL MICROBIOLOGY REVIEWS
- RND-type drug efflux pumps from Gram-negative bacteria: molecular mechanism and inhibition
- (2015) Henrietta Venter et al. Frontiers in Microbiology
- Properties of AdeABC and AdeIJK Efflux Systems of Acinetobacter baumannii Compared with Those of the AcrAB-TolC System of Escherichia coli
- (2014) Etsuko Sugawara et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Role of the BaeSR two-component system in the regulation of Acinetobacter baumannii adeAB genes and its correlation with tigecycline susceptibility
- (2014) Ming-Feng Lin et al. BMC MICROBIOLOGY
- Antibacterial activity of lichen secondary metabolite usnic acid is primarily caused by inhibition of RNA and DNA synthesis
- (2014) Monika Maciąg-Dorszyńska et al. FEMS MICROBIOLOGY LETTERS
- Major Variation in MICs of Tigecycline in Gram-Negative Bacilli as a Function of Testing Method
- (2014) D. Marchaim et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Expression of the adeB gene and responsiveness to 1-(1-naphthylmethyl)-piperazine and phenylalanyl-arginyl- -naphthylamide in clinical isolates of Acinetobacter baumannii
- (2013) T. Dal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efflux-Mediated Antibiotic Resistance inAcinetobacterspp.
- (2010) Sébastien Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Understanding antimicrobial activities of phytochemicals against multidrug resistant bacteria and biofilms
- (2009) Manuel Simões et al. NATURAL PRODUCT REPORTS
- Review of Usnic Acid andUsnea BarbataToxicity
- (2008) LEI GUO et al. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now